CONTAK CD CRT-D MODELS H115 H119 AND CONTAK RENEWAL CRT-D MODELS H120 H125

Cardiac related image

A Cardiac Resynchronization Therapy Defibrillators (CRT-D) Related Image

(Not Necessarily related to the device)

Description:

CONTAK CD CRT-D Models H115, H119 and CONTAK RENEWAL CRT-D Models H120, H125 by Boston Scientific Corp.

Boston Scientific Corp. presents the highly effective CONTAK CD CRT-D Models H115, H119 and CONTAK RENEWAL CRT-D Models H120, H125. These advanced devices are designed to enhance patient care in cardiac therapy.

They are Cardiac Resynchronization Therapy Defibrillators (CRT-D) principally designed to treat heart rhythm disorders by delivering tiny electrical signals to the heart. This technology aids in managing disorders like bradycardia, tachycardia, and heart failure.

The unique aspect of these devices is their dual ability to provide both pacing and defibrillation. The pacing functionality helps to correct slow heart rhythms, whereas the defibrillation feature reinstates the heart's normal rhythm during dangerously accelerated heart rhythms.

The CONTAK CD CRT-D Models H115, H119 and CONTAK RENEWAL CRT-D Models H120, H125 stand out in the industry for their potential benefits. These include improving the quality of life for patients by reducing symptoms of heart rhythm disorders, such as fatigue and shortness of breath. They can also contribute to a decreased risk of hospitalization due to heart failure.

In summary, these devices by Boston Scientific Corp. are a comprehensive solution for managing various heart rhythm disorders, offering both efficiency and relief for patients.

Primary Use:

Primary Medical Use of CONTAK CD CRT-D Models H115 H119 and CONTAK RENEWAL CRT-D Models H120 H125

Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), such as the CONTAK CD CRT-D Models H115 H119 and CONTAK RENEWAL CRT-D Models H120 H125, are remarkable advancements in the arsenal of tools available to medical professionals managing cardiac ailments in their practices. A CRT-D device such as these models both monitors and administers therapy for the heart rhythm. Its primary function is to treat patients with moderately to severely symptomatic heart failure due to a reduced ejection fraction and dyssynchronous ventricular contractions. It does this by delivering electrical shocks to the heart to restore the normal rhythm when it detects life-threat

How It Works:

Understanding the CONTAK CD CRT-D MODELS H115 H119 and CONTAK RENEWAL CRT-D MODELS H120 H125

Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) like the CONTAK CD and CONTAK RENEWAL models are advanced cardiac devices that serve dual purposes - pacing the heart in synchrony and delivering therapeutic shocks when required. These sophisticated devices are particularly beneficial for patients with heart failure (HF) who also have an abnormal heart rhythm known as ventricular dysynchrony.

The Operation Procedure of CRT-D Devices

CRT-Ds combine the technologies of a pacemaker and an Implantable Cardioverter Defibrillator (ICD) into one unit. It achieves synchronization via dual chamber pacing or biventricular pacing, stimulating both the left and right ventricles to contract simultaneously, maximizing cardiac output. The defibrillator component of the CONTAK CD/RENEWAL CRT-D models monitors the heart rhythm continuously. In the event of a life-threatening ventricular arrhythmia, the device delivers a therapeutic shock to restore a healthy rhythm.

Significance of CRT-D Technology

CRT-D devices not only rectify the dysfunctional cardiac rhythm but also improve the quality of life and functionality of HF patients, reduce hospitalization rates, and enhance overall survival. Its significance is particularly magnified in patients with advanced heart failure symptoms and a prolonged QRS duration, where CRT-D proves to be superior in improving cardiac functions and mortality rates compared to solely medication therapy. By expertly combining pacing and defibrillation technologies, CONTAK CD and CONTAK RENEWAL CRT-D models fortify the medical arsenal in the battle against heart failure and associated life-threatening arrhythmias. They stand testament to our relentless pursuit of innovation in healthcare, harnessing cutting-edge technology to save lives and improve patient outcomes.

Manufacturer:

Boston Scientific Corp.

Status: In Stock

Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.